Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Data on adefovir dipivoxil against HBV presented at EASL conference

April 16, 1999

Neurokinin antagonists for IBS synthesized and evaluated at Solvay

April 15, 1999

FDA requires further info about Hepagene vaccine

April 15, 1999

Colazide receives pricing approval in Sweden

April 14, 1999

Korea research institute describes new compounds with reversible antisecretory activity

April 12, 1999

Preclinical results indicate potential value of clevudine in chronic HBV infections

April 9, 1999

Neurokinin antagonists from Solvay particularly useful for GI disorders

April 9, 1999

Phase III trial of Aliminase in ulcerative colitis initiated

April 9, 1999

VRT-21493: a representative new HCV NS3 protease inhibitor designed by Vertex

April 8, 1999

Available for licensing from NIH: cloned genomes of infectious HCV and uses thereof

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.